Health Apr 30 Critical study of Gilead drug shows coronavirus patients responding to treatment, NIH says Gilead said a government-run study of remdesivir, perhaps the most closely watched experimental drug to treat Covid-19, showed the medicine is effective.
Science Nov 20 First CRISPR treatment for sickle cell, other blood disease shows early benefits in two patients The first two patients to receive a CRISPR-based treatment for the inherited blood disorders sickle cell disease and beta thalassemia have benefited from the experimental therapy and experienced only temporary and treatable side effects.